Assessment of subclinical atherosclerosis and cardiovascular risk

Clinical Cardiology

Volumn 24, Issue 10, 2001, Pages 642-650

  Benitez, R M ^a   Vogel, R A ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Brachial artery reactivity; Cardiac risk; Electron beam computed tomography; Magnetic resonance angiography

Indexed keywords

HOMOCYSTEINE;

ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HEMOSTASIS; HUMAN; INFECTION; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; REVIEW; RISK ASSESSMENT;

EID: 0034816876     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960241003     Document Type: Review

References (112)

1. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
2. Kafonek: The lipid treatment assessment project (L-TAP)
3. Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease. The heart and estrogen/progestin replacement study (HERS)
4. Detection of coronary artery calcification during life
5. The diagnostic and prognostic significance of coronary artery calcification: A report of 800 cases
6. Absence of coronary calcification on double-helical CT scans: Predictor of angiographically normal coronary arteries in elderly women?
7. Coronary artery calcification in women with syndrome X: Usefulness of double-helical CT for detection
8. Comparison of electron beam and helical computed tomography in assessment of coronary artery calcification (abstr)
9. Ultrafast computed tomography as a diagnostic modality in the detection of CAD: A multicenter study
10. Ultrafast tomographic detection of coronary artery calcification as an indicator of stenosis
11. Screening for coronary artery atherosclerosis by detection of calcium on electron beam computed tomography: Correlation with intravascular ultrasound in asymptomatic patients with primary hyperlipidemia
12. Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography
13. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease
14. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease
15. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography
16. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography
17. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults
18. Predictive value of electron beam computed tomography of the coronary arteries-19 month follow up of 1,173 asymptomatic subjects
19. Identifying adults at increased risk of coronary disease
20. Electron beam computed tomographic coronary calcium as a predictor of coronary events. Comparison of two protocols
21. Coronary artery disease: Improved reproducibility of calcium scoring with an electron beam CT volumetric method
22. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease
23. Magnetic resonance imaging of the coronary arteries: Clinical results from three dimensional evaluation of a respiratory gated technique
24. Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography
25. Coronary arteries: MR angiography with fast contrast enhanced three dimensional breath hold imaging-initial experience
26. Differences between normal subjects and patients with coronary artery disease for three different MR coronary angiography respiratory suppression techniques
27. Fast magnetic resonance imaging of the heart
28. Coronary MR angiography
29. Visualization of functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging
30. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men
31. Relationship between arterial disease at different sites
32. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease
33. Association of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery
34. Beneficial effects of colestipol-niacin therapy on the common carotid
35. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II)
36. Effect of lovastatin on early carotid atherosclerosis and clinical events
37. Kuopio Atherosclerosis Prevention Study (KAPS)-a population based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
38. B-scan ultrasound examination of the carotid arteries within a representative population (MONICA project Augsburg)
39. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case control study
40. Carotid intimal-medial thickness: Correlation with the British regional heart study risk score
41. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The atherosclerosis risk in communities (ARIC) study, 1987-1993
42. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
43. Common carotid intima-media thickness and arterial stiffness-indicators of cardiovascular risk in high-risk patients
44. The role of carotid arterial intima-medial thickness in predicting clinical coronary events
45. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
46. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different stages of coronary atherosclerosis
47. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: Possible role of early coronary atherosclerosis
48. Close relation of endothelial function in the human coronary and peripheral circulations
49. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease
50. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
51. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
52. Vascular function correlates with risk factors for cardiovascular disease in a healthy population of 35-year-old subjects
53. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease
54. Smoking correlates with flow-mediated brachial artery vasoactivity but not cold pressor vasoactivity in men with coronary artery disease
55. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease
56. Exercise training enhances endothelial function in young men
57. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
58. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease
59. Effect of a short-term primary prevention program on endothelium-dependent vasodilation in adults at risk for atherosclerosis
60. Changes in flow-mediated brachial artery vasoreactivity with lowering of desirable cholesterol levels in healthy middle-aged men
61. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
62. Correlation of cold pressor and flow-mediated brachial artery diameter responses with the presence of coronary artery disease
63. Systemic endothelial dysfunction is related to the extent and severity of coronary of coronary artery disease
64. The correlation between stenosis index and flow-mediated dilation of the brachial artery
65. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease
66. Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease
67. Inflammation, atherosclerosis, and ischemic eventsexploring the hidden side of the moon
68. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
69. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s)
70. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae
71. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae
72. A Chlamydia pneumoniae component that induces macrophage foam cell formation is a chlamydial lipopolysaccharide
73. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor alpha and matrix metalloproteinase expression
74. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
75. Chlaraydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-Kappa B and induces tissue factor and PAI-1 expression: A potential link to arteriosclerosis
76. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
77. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infarction with Chlamydia (ACADEMIC) Study
78. Treatment with the antibiotic roxithromycin in patients with acute non-Q wave coronary syndromes. The final report of the ROXIS study
79. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
80. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion
81. The leukocyte count as a predictor of myocardial infarction
82. Leukocyte count, smoking and myocardial infarction
83. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality
84. Leukocyte counts and coronary heart disease in a Japanese cohort
85. White blood cell count and cardiovascular disease-insights from the Framingham Study
86. Leukocytes as a coronary risk factor in a dyslipidemic male population
87. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
88. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
89. Long-term effects of pravastatin on plasma concentration of c-reactive protein
90. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA Augsburg cohort study, 1984-1992
91. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
92. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
93. Fibrinogen and cardiovascular risk
94. Risk factors for coronary heart disease and acute phase proteins. A population based study
95. Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis
96. -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute phase reaction pattern of fibrinogen
97. Platelet glycoprotein polymorphism and risk for coronary heart disease
98. DNA polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit: Is there a relation with the low risk of cardiovascular disease in Inuit?
99. Coagulation factor VII and the risk of coronary heart disease in healthy men
100. Factor VII polymorphisms in populations with different risks of cardiovascular disease
101. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical atherosclerosis
102. Prospective study of markers of hemostatic function with risk of ischemic stroke
103. Hemostatic tests in the prediction of atherothrombotic disease
104. Plasma viscosity and the risk of coronary heart disease: Results from the MONICA Augsburg cohort study, 1984-1992
105. Soluble thrombomodulin as apredictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study
106. Vascular pathology of homocysteinemia
107. Natural history of homocysteinuria due to cystathione beta synthase deficiency
108. Hyperhomocysteinemia induced vascular damage in the minipig. Captoprilhydrochlorothiazide combination prevents elastic alterations
109. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia
110. Acute hyperhomocysteinemia and endothelial dysfunction
111. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association
112. Prediction of coronary heart disease using risk factor categories